ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 271

Bone Marrow Lesions in Knees with Osteoarthritis: Can Parameters From Dynamic Contrast Enhancement Predict Change in Bone Marrow Lesion Volume or Knee Pain Change?

Andrew D. Gait1, Timothy F. Cootes1, Elizabeth J. Marjanovic1, Matthew J. Parkes2, Charles E. Hutchinson3 and David T. Felson4, 1Imaging Sciences, School of Cancer & Enabling Sciences, University of Manchester, Manchester, United Kingdom, 2Arthritis Research UK Centre for Epidemiology, Institute of Inflammation and Repair, University of Manchester, Manchester, United Kingdom, 3Warwick Medical School, University of Warwick, Coventry, United Kingdom, 4ARC Epidemiology Unit, University of Manchester, Manchester, United Kingdom

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Bone marrow, imaging techniques and osteoarthritis, Knee

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Dynamic contrast enhancement is a powerful tool for highlighting features of a medical image which may not otherwise be seen on “static” scans. While used extensively in other settings, it has not been used until now to study bone marrow lesions (BMLs) in osteoarthritis (OA), lesions which vary over time in volume and change with knee pain.

Methods:

We studied 23 patients who had patellofemoral (PF) OA. All met ACR criteria for knee OA and were participating in a trial of PF knee braces. All patients had no treatment at baseline, were on brace at 12 weeks and acquired MRI’s with a gadolinium(Gd)-enhanced dynamic image sequence at both times.

Within these knees, 40 PF or femoral BMLs were manually segmented at baseline and 12 weeks on sagittal Gd-enhanced images (TR 500ms, TE 17ms, FoV 16cm, 384×384). Knee osteoarthritis outcome score (KOOS) pain data was collected at each time.

We assessed dynamic parameters within BMLs in two steps: (1) transforming the segmented BML from the sagittal sequence to the axial dynamic sequence (TR 5.4ms, TE 1.9ms, FoV 14cm, 256×256); (2) using the extended Kety model (Tofts 1997) to calculate the parameters ve (fractional extracellular volume), vp (fractional blood plasma volume) and Ktrans (transfer coefficient from vp to ve:a direct measure of perfusion) at each voxel. The mean of each parameter was calculated for each BML (one to three per patient), taking care to ensure that this was done consistently between the baseline and 12 week images. The distribution of Ktrans within the BMLs was heterogeneous and limited to small volumes, so to avoid averaging of diverse values, we examined peak Ktrans value in the BML also. To compare with KOOS, mean parameters and peak Ktrans value were examined across all BMLs within a knee.

To evaluate the relation of the parameters to BML volumes and KOOS, we calculated Spearman rank correlation coefficients.

Results:

After 12 weeks, change in mean values of the parameters Ktrans, ve and vp did not correlate either with change in volume of the BML (Ktrans: r=0.02; ve: r=-0.07; vp: r=0.02) or change in KOOS (Ktrans: r=0.18; ve: r=0.03; vp: r=0.09). Change in the peak value of Ktrans correlated better with change in volume of the BML (r=0.43: p=0.0056, see figure) but not with KOOS (r=-0.11).

Conclusion:

There are no clear correlations between the means of the parameters Ktrans, ve and vp and change in BML volume or KOOS. The peak Ktrans value of a BML may be related to its likelihood of undergoing change.


Disclosure:

A. D. Gait,
None;

T. F. Cootes,
None;

E. J. Marjanovic,
None;

M. J. Parkes,
None;

C. E. Hutchinson,
None;

D. T. Felson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bone-marrow-lesions-in-knees-with-osteoarthritis-can-parameters-from-dynamic-contrast-enhancement-predict-change-in-bone-marrow-lesion-volume-or-knee-pain-change/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology